Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00142727 · ClinicalTrials.gov registry record · Phase 2
Opioid Agonist and Antagonist Effects on Opioid Dependence
A Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).
- Terminated
- Registry status
- Phase 2
- Development phase
- 16
- Enrollment target
NCT00142727 is a Phase 2 study that was terminated before completion, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 16 participants.
The verdict
NCT00142727, a Phase 2 study, was terminated before completion, sponsored by National Institute on Drug Abuse (NIDA).
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the acute agonist and antagonist effects of a full opioid agonist medication, an opioid antagonist medication, and a partial opioid agonist medication in individuals who have different levels of physical opioid dependence.
Interventions
- DRUG Methadone
- DRUG Full opioid agonist
- DRUG Partial opioid agonist
- DRUG Opioid antagonist
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2004-01 |
| Est. Completion | 2006-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00142727
The ClinicalTrials.gov registry entry for NCT00142727 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Methadone is the first listed.
NCT00142727 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00142727 about?
NCT00142727 is a clinical study titled "Opioid Agonist and Antagonist Effects on Opioid Dependence". The purpose of this study is to examine the acute agonist and antagonist effects of a full opioid agonist medication, an opioid antagonist medication, and a partial opioid agonist medication in individuals who have different levels of physical opioid dependence.
What is the current status of trial NCT00142727?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2004-01. Estimated completion is 2006-02.
What interventions are being tested in trial NCT00142727?
The interventions under investigation include: Methadone (DRUG), Full opioid agonist (DRUG), Partial opioid agonist (DRUG), Opioid antagonist (DRUG).
Who is sponsoring clinical trial NCT00142727?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.